Ironwood Pharma (IRWD) – Analyst EPS View
-
Ironwood Pharmaceuticals (IRWD) PT Lowered to $23 at Mizuho Securities on Reduced Linzess Growth Outlook; 'Sell-Offer Overdone'
-
JPMorgan Downgrades Ironwood Pharmaceuticals (IRWD) to Neutral
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
Back to IRWD Stock Lookup